Evidence map›Paper›PMID 32944602›Full record

ArticleData in brief2020

Imaging and clinical data indicate considerable disease burden in 'probable' PLS: Patients with UMN symptoms for 2-4 years.

Eoin Finegan, We Fong Siah, Stacey Li Hi Shing, Rangariroyashe H Chipika, Kai Ming Chang, Mary Clare McKenna, Mark A Doherty, Jennifer C Hengeveld, Alice Vajda, Colette Donaghy and 4 more

Open access · goldAbstract read
In one paragraph

Article in Data in brief, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Eoin FineganComputational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Ireland.
We Fong SiahComputational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Ireland.
Stacey Li Hi ShingComputational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Ireland.
Rangariroyashe H ChipikaComputational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Ireland.
Kai Ming ChangComputational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Ireland.
Mary Clare McKennaComputational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Ireland.
Mark A DohertyComplex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Ireland.
Jennifer C HengeveldComplex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Ireland.
Alice VajdaComplex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Ireland.
Colette DonaghyDepartment of Neurology, Western Health & Social Care Trust, Belfast, United Kingdom.
Siobhan HutchinsonDepartment of Neurology, St James's Hospital, Dublin, Ireland.
Russel L McLaughlinComplex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Ireland.
Orla HardimanComputational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Ireland.
Peter BedeComputational Neuroimaging Group, Biomedical Sciences Institute, Trinity College Dublin, Ireland.
Trinity College Dublin · IESt. James's Hospital · IEUniversity of Southampton · GBWestern Health and Social Care Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary lateral sclerosis (PLS) is an adult-onset upper motor neuron disease manifesting in progressive spasticity and gradually resulting in considerably motor disability. In the absence of early disease-specific diagnostic indicators, the majority of patients with PLS face a circuitous diagnostic journey. Until the recent publication of consensus diagnostic criteria, 4-year symptom duration was required to establish the diagnosis. The new diagnostic criteria introduced the category of 'probable PLS' for patients with a symptom duration of 2-4 years. "Evolving diagnostic criteria in primary lateral sclerosis: The clinical and radiological basis of "probable PLS" [1]. This dataset provides radiological metrics in a cohort of 'probable PLS' patients, 'definite PLS' patients and age-matched healthy controls. Region-of-interest radiological data include diffusivity metrics in the corticospinal tracts and corpus callosum as well as mean cortical thickness values in the pre- and para-central gyri in each hemisphere. Our data indicate considerable grey matter and relatively limited white matter involvement in 'probable PLS' which supports the rationale for this diagnostic category as a clinically useful entity. The introduction of this diagnostic category will likely facilitate the timely recruitment of PLS patients into research studies and pharmacological trials before widespread neurodegenerative change ensues.

Indexed as

MRINeuroimagingPrimary lateral sclerosisUpper motor neuron

Identifiers

PMID32944602
PMCPMC7481824
OpenAlexW3082360475

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.